Experimental Drug Shows Early Promise In Treating Male Baldness, Samumed Reveals

An experimental drug from a largely unknown biotechnology company has shown promise in regrowing bald men’s hair, according to data to be presented at the American Academy of Dermatology in Washington, D.C., today.

The result is preliminary, and doctors who reviewed the presentation ahead of publication for Forbes characterized the results as promising, but also raised concerns about whether or not it would hold up in larger studies.

Back to news